Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Minar

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|February 1, 2025
Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With VedolizumabCourtney Bartel, Phillip Minar
Gastroenterology Clinics of North America|August 5, 2023
The Role of Therapeutic Drug Monitoring in ChildrenAlexander Nasr, Phillip Minar
The American Journal of Gastroenterology|June 4, 2025
Comment on a Risk Stratification Tool for Relapse After Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel DiseasesThomas Aviles, Phillip Minar
Alimentary Pharmacology & Therapeutics|February 14, 2023
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' replyRuben J Colman, Phillip Minar
Current Gastroenterology Reports|September 11, 2023
Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel DiseaseAbigail Samuels, Kaitlin G Whaley, Phillip Minar
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2012
An adolescent girl with belly pain: one gallbladder too many?Phillip Minar, Maria H Alonso, Milton T Smith, et al.
World Journal of Gastroenterology|December 6, 2017
Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel diseaseHuyen-Tran Nguyen, Phillip Minar, Kimberly Jackson, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 10, 2015
Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn DiseasePhillip Minar, Shehzad A Saeed, Mahrukh Afreen, et al.
Inflammatory Bowel Diseases|November 22, 2022
Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel DiseaseRuben J Colman, Abigail Samuels, Tomoyuki Mizuno, et al.
Pancreas|December 19, 2025
Markers of Gut Inflammation in Pediatric Acute PancreatitisVineet Garlapally, Faizan Ahmed, Kimberly Lynch, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|February 1, 2025
Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With VedolizumabCourtney Bartel, Phillip Minar
Gastroenterology Clinics of North America|August 5, 2023
The Role of Therapeutic Drug Monitoring in ChildrenAlexander Nasr, Phillip Minar
The American Journal of Gastroenterology|June 4, 2025
Comment on a Risk Stratification Tool for Relapse After Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel DiseasesThomas Aviles, Phillip Minar
Alimentary Pharmacology & Therapeutics|February 14, 2023
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' replyRuben J Colman, Phillip Minar
Current Gastroenterology Reports|September 11, 2023
Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel DiseaseAbigail Samuels, Kaitlin G Whaley, Phillip Minar
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2012
An adolescent girl with belly pain: one gallbladder too many?Phillip Minar, Maria H Alonso, Milton T Smith, et al.
World Journal of Gastroenterology|December 6, 2017
Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel diseaseHuyen-Tran Nguyen, Phillip Minar, Kimberly Jackson, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 10, 2015
Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn DiseasePhillip Minar, Shehzad A Saeed, Mahrukh Afreen, et al.
Inflammatory Bowel Diseases|November 22, 2022
Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel DiseaseRuben J Colman, Abigail Samuels, Tomoyuki Mizuno, et al.
Pancreas|December 19, 2025
Markers of Gut Inflammation in Pediatric Acute PancreatitisVineet Garlapally, Faizan Ahmed, Kimberly Lynch, et al.
Pageof 5